World's first national meningitis vaccine program launched in Britain

Britain's National Health Service became the first public health body in the world on Tuesday to agree to administer to newborns a new vaccine against potentially deadly meningitis B.

Experts said over the next decade the vaccine could potentially prevent more than 4,000 cases of meningococcal disease in children under five in Britain.

Infants aged under one are at the most risk of meningitis B infection, which is fatal in one in 10 cases.

Steve Dayman, founder of the charity Meningitis Now said: "We, along with our supporters, have campaigned for over two years to see the ground-breaking vaccine free on the NHS."

"I'm absolutely elated that we now have this vaccine being used to protect our babies. I've waited 33 years since losing my baby to the same strain for this day to happen."

"We're delighted to reach this milestone - it's a tribute to our supporters' selfless and tireless efforts. Whilst this is good news - this does not mean meningitis is beaten. Our message is 'don't become complacent about meningitis' - there are still not vaccines for all types."

Sue Davie, the charity's CEO said: "The infant Men B immunization program will be available for two-month-olds, with another dose at four months, and a booster at 12 months. There is still more to do and we will continue our campaigning to see the Men B vaccine extended to other at-risk groups."

Dr. Mary Ramsay, head of immunization at Public Health England said: "This vaccine will help to save lives and prevent permanent disability. Meningococcal B disease can be devastating for babies and young children and it has cut many lives short and left young people disabled."

"We must all remain alert to the signs and symptoms of meningococcal disease and seek urgent medical attention if there is any concern as the vaccine does not protect against all types." Endit